DNA methylation risk score for type 2 diabetes is associated with gestational diabetes.

"Declarations Ethics approval and consent to participateThe Norwegian Regional Committee for Medical Health Research Ethics South East approved the STORK-G study including genetic and epigenetic data (ref. number 2015/1035). And the EPIDG study was approved by the Institutional review board at the Hospital Universitario Virgen de la Victoria, Málaga. Written informed consent from all participants was obtained before any study-related procedure. Consent for publicationAll authors revised the manuscript critically and approver the final version. Conflict of interestThe authors declare there is no conflict of interest. Conflict of interest The authors declare there is no conflict of interest."

"Funding EPIPREG is supported by the South Eastern Norway Regional Health Authority (grant number: 2019092), and the Norwegian Diabetes Association (grant number: N/A). GH-M. is the recipient of an Australian Research Council Discovery Early Career Award (Project number: DE220101226) funded by the Australian Government and supported by the Research Council of Norway (Project grant: 325640). JO-O is supported by the Norwegian Research Council (Medical Student Research Program, grant 271555/F20). EPIDG was funded by the Juan Rodés program from “Instituto de Salud Carlos III” (JR20-00040 to MM-V), PFIS program (FI19/00178 to TML-P), and the Nicolas Monardes Program from the “Servicio Andaluz de Salud, Junta de Andalucía”, Spain (RC-0008-2021 to SM). In addition, this study was supported by the research grants from the ISCIII (PI18/01175, PI21/01864) and from “Servicio Andaluz de Salud”, Junta de Andalucía (PI-0283-2018, PI-0419-2019). This study has been co-funded by FEDER funds (“A way to make Europe”)."